Global Interferon Alpha-2a Biosimilar Market Data Survey Report 2025

November 2018 | 74 pages | ID: G2602A06848EN
HeyReport

Abstracts

Summary

Interferon a (human leukocyte protein moiety reduced). A type I interferon consisting of 165 amino acid residues with lysine in position 23. This protein is produced by recombinant DNA technology and resembles interferon secreted by leukocytes. It is used extensively as an antiviral or antineoplastic agent. An oral form is being developed by Amarillo Biosciences.
The global Interferon Alpha-2a Biosimilar market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including:

Global market size and forecast

Regional market size, production data and export & import

Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)

Major Application

Major Type

Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:

• Roche
• Biosidus
• Zydus Cadila
• Nanogen
• Amega Biotech
• Rhein Minapharm Biogenetics
• Rhein Minapharm Biogenetics
• 3sbio

Major applications as follows:

• Hepatitis C
• Hepatitis B
• Other

Major Type
as follows:

• Long-lasting Type
• Ordinary Type

Regional market size, production data and export & import:

• Asia-Pacific
• North America
• Europe
• South America
• Middle East & Africa

Contents

1 GLOBAL MARKET OVERVIEW

1.1 Scope of Statistics
  1.1.1 Scope of Products
  1.1.2 Scope of Manufacturers
  1.1.3 Scope of Application
  1.1.5 Scope of Regions/Countries
1.2 Global Market Size

2 REGIONAL MARKET

2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade

3 KEY MANUFACTURERS

3.1 Roche
  3.1.2 Company Information
  3.1.2 Product Specifications
  3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 Biosidus
  3.2.1 Company Information
  3.2.2 Product Specifications
  3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Zydus Cadila
  3.3.1 Company Information
  3.3.2 Product Specifications
  3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 Nanogen
  3.4.1 Company Information
  3.4.2 Product Specifications
  3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 Amega Biotech
  3.5.1 Company Information
  3.5.2 Product Specifications
  3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 Rhein Minapharm Biogenetics
  3.6.1 Company Information
  3.6.2 Product Specifications
  3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 Rhein Minapharm Biogenetics
  3.7.1 Company Information
  3.7.2 Product Specifications
  3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 3sbio
  3.8.1 Company Information
  3.8.2 Product Specifications
  3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)

4 MAJOR APPLICATION

4.1 Hepatitis C
  4.1.1 Overview
  4.1.2 Hepatitis C Market Size and Forecast
4.2 Hepatitis B
  4.2.1 Overview
  4.2.2 Hepatitis B Market Size and Forecast
4.3 Other
  4.3.1 Overview
  4.3.2 Other Market Size and Forecast

5 MARKET BY TYPE

5.1 Long-lasting Type
  5.1.1 Overview
  5.1.2 Long-lasting Type Market Size and Forecast
5.2 Ordinary Type
  5.2.1 Overview
  5.2.2 Ordinary Type Market Size and Forecast

6 CONCLUSION

List Of Tables

LIST OF TABLES

Tab REGIONAL PRODUCTION 2011-2017 (MILLION USD)
Tab Regional Production 2011-2017 (Volume)
Tab Regional Demand and CAGR 2011-2017 (Million USD)
Tab Regional Demand and CAGR 2011-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Regional Export 2011-2017 (Million USD)
Tab Regional Export 2011-2017 (Volume)
Tab Regional Import 2011-2017 (Million USD)
Tab Regional Import 2011-2017 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of Roche
Tab Sales Revenue, Volume, Price, Cost and Margin of Biosidus
Tab Sales Revenue, Volume, Price, Cost and Margin of Zydus Cadila
Tab Sales Revenue, Volume, Price, Cost and Margin of Nanogen
Tab Sales Revenue, Volume, Price, Cost and Margin of Amega Biotech
Tab Sales Revenue, Volume, Price, Cost and Margin of Rhein Minapharm Biogenetics
Tab Sales Revenue, Volume, Price, Cost and Margin of Rhein Minapharm Biogenetics
Tab Sales Revenue, Volume, Price, Cost and Margin of 3sbio

List Of Figures

LIST OF FIGURES

Fig Global Interferon Alpha-2a Biosimilar Market Size and CAGR 2011-2017 (Million USD)
Fig Global Interferon Alpha-2a Biosimilar Market Size and CAGR 2011-2017 (Volume)
Fig Global Interferon Alpha-2a Biosimilar Market Forecast and CAGR 2018-2025 (Million USD)
Fig Global Interferon Alpha-2a Biosimilar Market Forecast and CAGR 2018-2025 (Volume)
Fig Hepatitis C Market Size and CAGR 2011-2017 (Million USD)
Fig Hepatitis C Market Size and CAGR 2011-2017 (Volume)
Fig Hepatitis C Market Forecast and CAGR 2018-2025 (Million USD)
Fig Hepatitis C Market Forecast and CAGR 2018-2025 (Volume)
Fig Hepatitis B Market Size and CAGR 2011-2017 (Million USD)
Fig Hepatitis B Market Size and CAGR 2011-2017 (Volume)
Fig Hepatitis B Market Forecast and CAGR 2018-2025 (Million USD)
Fig Hepatitis B Market Forecast and CAGR 2018-2025 (Volume)
Fig Other Market Size and CAGR 2011-2017 (Million USD)
Fig Other Market Size and CAGR 2011-2017 (Volume)
Fig Other Market Forecast and CAGR 2018-2025 (Million USD)
Fig Other Market Forecast and CAGR 2018-2025 (Volume)
Fig Long-lasting Type Market Size and CAGR 2011-2017 (Million USD)
Fig Long-lasting Type Market Size and CAGR 2011-2017 (Volume)
Fig Long-lasting Type Market Forecast and CAGR 2018-2025 (Million USD)
Fig Long-lasting Type Market Forecast and CAGR 2018-2025 (Volume)
Fig Ordinary Type Market Size and CAGR 2011-2017 (Million USD)
Fig Ordinary Type Market Size and CAGR 2011-2017 (Volume)
Fig Ordinary Type Market Forecast and CAGR 2018-2025 (Million USD)
Fig Ordinary Type Market Forecast and CAGR 2018-2025 (Volume)